Vivoz Biolabs develops cell culture platforms that are designed to mimic the dynamic 3D tumor microenvironment.
Vivoz Biolabs develops cell culture platforms that are designed to mimic the dynamic 3D tumor microenvironment. The company aims to commercialize its layered microfluidic tissue assay, a patented technology that can be used as an ex vivo platform for drug screening and diagnosis, and a device for personalized cancer treatment.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 2, 2019 | Grant | $224.70K | 1 | National Science Foundation | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Science Foundation | Yes | Grant |